| 000 | 01757 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517072428.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1573-7373 | ||
| 024 | 7 |
_a10.1007/s11060-015-2028-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrowd, Roy E | |
| 245 | 0 | 0 |
_aThe role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cMar 2016 |
||
| 300 |
_a165-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAstrocytoma _xdrug therapy |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLomustine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aAbuali, Inas | |
| 700 | 1 | _aYe, Xiaobu | |
| 700 | 1 | _aLu, Yao | |
| 700 | 1 | _aGrossman, Stuart A | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 127 _gno. 1 _gp. 165-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11060-015-2028-2 _zAvailable from publisher's website |
| 999 |
_c25597860 _d25597860 |
||